Correction: Previous press release had an incorrect MAR reference.
First Berlin Equity Research publishes independent analysis of Cyxone Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that the internationally renowned research company First Berlin Equity Research has published an independent analysis report of Cyxone.The independent analysis covers the first quarter of 2020 and was published on 26 June 2020, where First Berlin reviewed the company’s potential with an expected but continued positive outcome. The report in English can be read in its entirety on the Cyxone’s website. ContactTara Heitner, CEOTel: +46 70